Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-LIV-1 ANTIBODY, DRUG CONJUGATE THEREOF, AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/109944
Kind Code:
A1
Abstract:
Provided are a LIV-1 binding molecule and a preparation method therefor, and a corresponding immunoconjugate, a pharmaceutical composition, a medical use, and a method for preventing a disease, in particular a method for treating cancer or a tumor.

Inventors:
DONG LIWEI (CN)
ZHANG WEI (CN)
CHEN SIMENG (CN)
WANG LILI (CN)
LIAO CHENG (CN)
Application Number:
PCT/CN2023/134161
Publication Date:
May 30, 2024
Filing Date:
November 24, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
SHANGHAI SHENGDI PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K39/395; C07K16/28; A61P35/00; C07K16/30; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/09; C12N15/12; C12N15/13; C12N15/63
Foreign References:
CN103533957A2014-01-22
CN106999517A2017-08-01
CN114206933A2022-03-18
CN1849337A2006-10-18
US20040141983A12004-07-22
US20050175619A12005-08-11
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF: